ACRS Dividend History & Analysis | N/A Yield
ACRS has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| SIGA | 480 M | 10.4% | 12.2% |
| GS71 | 118,497 M | 4.22% | 7.28% |
| BMY | 113,778 M | 4.98% | 5.04% |
| SAN | 113,221 M | 4.30% | 5.91% |
| SNY | 114,158 M | 4.43% | 5.55% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| ZTS | 54,250 M | 18.9% | 100% |
| VIRP | 3,475 M | 17.9% | 82.1% |
| LLY | 915,139 M | 15.3% | 99.5% |
| BMY | 113,778 M | 14.0% | 92.6% |
| MRK | 64,417 M | 12.0% | 91.8% |
Quality Dividend Peers in Pharmaceuticals
4.98% Yield
3.70% Yield
3.02% Yield
3.68% Yield
1.34% Yield
2.08% Yield
ACRS Dividend History: as of February 2026
No dividends paid yet.ACRS Dividend FAQ
Aclaris Therapeutics (NASDAQ: ACRS) is a clinical-stage biopharma focused on novel immuno-inflammatory therapies in the United States, operating through a Therapeutics segment (drug discovery and development) and a Contract Research segment (laboratory services). Its pipeline includes a soft JAK 1/3 inhibitor (ATI-1777) in Phase 2b for atopic dermatitis, an anti-TSLP antibody (Bosakitug/ATI-045) in Phase 2a for multiple airway and skin diseases, an oral ITK/JAK3 covalent inhibitor (ATI-2138) in Phase 2a, a MAPK-activated protein kinase-2 inhibitor (Zunsemetinib/ATI-450) in early-stage oncology trials, and a bispecific anti-TSLP/IL-4R antibody (ATI-052) still in preclinical work.
What is the Dividend Yield of ACRS?
As of February 2026, ACRS`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 3.57.Does ACRS pay a dividend?
As of February 2026 ACRS does not pay a dividend.How often does ACRS pay dividends?
Over the last 12 months, ACRS has issued dividend payments.ACRS dividend forecast
Based on historical data, the forecasted dividends per share for ACRS for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will ACRS pay dividends in 2026?
The next Ex-Dividend date for Aclaris Therapeutics (ACRS) is currently unknown.What is the next Ex-Dividend Date for ACRS?
The next Ex-Dividend date for Aclaris Therapeutics (ACRS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of ACRS?
ACRS's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of ACRS?
ACRS's 5-Year Yield on Cost is -%. If you bought ACRS's shares at 20.95 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of ACRS?
ACRS Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does ACRS have a good Dividend Yield?
ACRS`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of ACRS?
The Dividend Payout Ratio of ACRS is unknown.What is the Dividend Rating of ACRS?
ACRS`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-01-30 14:20